Graham J Galloway1,2, Scott G Quadrelli1,3,4, Aaron J Urquhart1, Katie Trickey1, Peter Malycha1, Theresa Keane5, and Carolyn E Mountford1
1Translational Research Institute, Woolloongabba, Australia, 2Centre for Advanced Imaging, The University of Queensland, Brisbane, Australia, 3University of Newcastle, Australia, 4Institute for Health and Biomedical Innovation, Brisbane, Australia, 5Department of Defence, Australian Government, Sydney, Australia
Synopsis
This pilot study reports clear deregulation
in the neurochemistry of defense
personnel exposed to repeated blast. The changes recorded are different to those reported for
mTBI, PTSD and chronic pain. No differences between blast exposed and healthy
were recorded by MRI
sequences T1WI, FLAIR or SWI. In vivo neuro 2D spectroscopy recorded deregulation with PC and GPC, NAA
and GABA all decreased compared to the healthy non exposed brain. We we did not
observe any changes in the fucosolated glycans, which are reflective of pain,
repetitive brain injury and/or cognitive
deficit.
Introduction
Blast injury,
depending on length and level of exposure, can result in the full spectrum of
traumatic brain injury (TBI) from mild to severe TBI and is common in combat. It is estimated that 60-80% of the soldiers,
exposed to a blast, will acquire a TBI [1] and
that injury can occur from a blast, without physical injury [2]. The sequelae of blast induced mTBI is similar to non-blast related
mTBI with the majority of individuals suffering no long term effects. There is
a risk of post concussive syndrome, chronic traumatic encephalopathy (CTE) (repeated
blast), and/or PTSD. In a retrospective review of the medical records of 27,169
U.S. Army Special Operations Command personnel, respondents with blast
associated mTBI (OR = 4.23) were at significantly greater risk of reporting
PTSD symptoms [3].
It is
hypothesised that 2D Correlated SpectroscopY (COSY) will identify early neurochemical
deregulation in the brain of those exposed to blast prior to changes recorded
by clinical MRI sequences.Purpose
Determine, using neuro 1D and 2D COSY, if there is neuro deregulation in subjects exposed to chronic low dose blast
injury as a result of using repeated artillery firing or explosive methods of entry (breaching) or common sources of blast exposure within the
defense forces. The results will be compared with standard clinical MRI
sequences, T1WI, FLAIR and SWI.Methods
Age
matched male participants, healthy (n=8) and blast exposed (n=8), were screened
to assess pre-existing exposure to traumatic brain injury using the Ohio State
University Traumatic Brain Injury Identification Method [4]. The Life Events Checklist for DSM-5
[5] was administered to ascertain
lifetime exposure to traumatic events known potentially to cause post-traumatic
stress disorder. Participants were then assessed using the Structured Clinical
Interview for DSM-5, [6] and excluded if they met diagnostic
criteria for any mental health problems, including PTSD.
One-dimensional (1D) and two-dimensional
(2D) localised COrrelation SpectroscopY (L-COSY) MRS was acquired from the
posterior cingulate gyrus (PCG) using a 3T Prisma MRI scanner (Siemens
Healthcare, Erlangen, Germany). MRS was performed on 8 blast exposed participants.
Comparisons were made with a healthy, approximately age and gender-matched
control group (n=8). Data were acquired
from a 3x3x3 cm3 voxel. 1D profiles were analysed with LCModel
(v6.2-2B) using water normalization.
Felix 2007 software was used for the processing and analysis of the 2D
L-COSY data. The creatine methyl
resonance (3.02-3.02ppm) was used as the internal chemical shift reference and for
volume normalisation of 2D L-COSY. Average peak areas/volumes were calculated
for each assigned metabolite and compared using a t-test. MRI sequences 3D
MP-RAGE (TR/TE/TI = 2530/3.5/1100msec), FLAIR (TR/TE/TI =5000/394/1800ms, and Siemens 3D SWI(TR/TE/FA = 20/27/15msec) were
recorded using 64 channel headcoil and visually inspected for lesions.Results
None of the blast
exposed patients showed structural brain abnormalities on T1 images, nor abnormalities
with SWI or FLAIR. However there were significant reductions in neurochemicals recorded
in the 1D and 2D spectra of those exposed to blast. The sum of phosphoryl
choline (PC) and Glycero-phosphocholine (GPC) was consistently reduced in the
blast exposed cohort compared to controls with a reduction of 19% (p<0.05) (1D
data) and 18% (p<0.005) (2D data). LC model showed reduction in NAA at
2.02ppm of 17% (p<0.01) in 1D data but this was not significant in the 2D
data sets (diagonal peak at 2.02ppm). The NAA cross peak at (F2: 4.36, F1:2.55ppm) was however decreased by 8% (p<0.03) in the
blast cohort . The 1D data showed a decrease of 26% (p<0.01) in phosphocreatine
(PCr), but as the 2D spectra were normalised to Creatine, comparison with 2D
COSY not possible. 1D spectra showed a 23% decrease (p<0.01) in GABA, which
was not reflected in the 2D spectra. There were significant a decreases in two,
unassigned peaks in the 2D-COSY spectra: (2.36,2.67ppm) by 11.6% (p<0.05) and (3.18,3.54ppm) by 15% (<0.05).
Discussion and Conclusion
Neuro 1D and 2D in vivo spectroscopy show quite large
and statistically significant changes in blast exposed subjects not recorded by imaging
techniques. Compared to normal healthy controls, PC and GPC were reduced reflecting reduced membrane synthesis; decreases in NAA
and GABA suggesting neuronal activity is affected and
the decrease in PCr suggests mitochondrial
dysfunction. No changes were recorded in the fucosolated glycans[7], which are reflective of
pain [8], CTE [9] and cognitive deficit.[10]. This pilot study reports
clear deregulation in the neurochemistry of defense personal exposed to repeated blast.
The changes are different to those reported for mTBI, PTSD and chronic pain.Acknowledgements
Funding was provided
by US and Australian DoD CDMRP (W81XWH-10-1-0835),
The authors
acknowledge the support of team members Valerie Graves and Lisa Rich for
project management, Dr Saad Ramadan, for development of the L-COSY sequence,
and radiographers Jameen Arm and Kylie Waters for implementing the protocols
and running the scanner. We thank Defence personnel Drs Helen Cartledge, Patrick Cullinan and Amanda Toman
for operational aspects.References
1. Wilk, J.E., et al.,
Mild traumatic brain injury (concussion)
during combat: lack of association of blast mechanism with persistent
postconcussive symptoms. J Head Trauma Rehabil, 2010. 25(1): p. 9-14.
2. Bhattacharjee, Y., Neuroscience. Shell shock revisited: solving
the puzzle of blast trauma. Science, 2008. 319(5862): p. 406-8.
3. Kontos, A.P., et
al., Residual effects of combat-related
mild traumatic brain injury. J Neurotrauma, 2013. 30(8): p. 680-6.
4. Corrigan, J.D.,
Bogner, J. A. , Initial reliability and
validity of the OSU TBI Identification Method. Journal of Head Trauma
Rehabilitation, 2007. 22(6): p.
318-329.
5. Weathers, M.B.,
Blake, D.D., Schnurr, P.P., Kaloupek, D.G., Marx, B.P. and Keane, T.M. The Life Events Checklist for DSM-5 (LEC-5).
Instrument available from the National Center for PTSD at www.ptsd.va.gov 2013.
6. First, M.B., Williams,
J. B. W., Karg, R. S., Spitzer, R. L. , Structured
Clinical Interview for DSM-5 – Research Version (SCID-5 for DSM-5, Research
Version; SCID-5 RV) 2015, Arlington, VA American Psychiatric Association.
7. Mountford, C., et
al., Six fucose-alpha(1-2) sugars and
alpha-fucose assigned in the human brain using in vivo two-dimensional MRS.
NMR Biomed, 2015. 28(3): p. 291-6.
8. Quadrelli SG, R.S.,
Lin A, Dimitrikof JD, Mountford CE,, α-Fucose increased in the brain of Chronic Pelvic Pain
Syndrome patients with inflammation at onset recorded by 2D L-COSY, in ISMRM. 2014: Milan.
9. Lin, A.P., et al., Changes in the neurochemistry of athletes
with repetitive brain trauma: preliminary results using localized correlated
spectroscopy. Alzheimer's Research & Therapy, 2015. 7(1): p. 13.
10. Murrey, H.E., et
al., Identification of the
Plasticity-Relevant Fucose-α(1-2)-Galactose Proteome from Mouse Olfactory Bulb.
Biochemistry, 2009. 48: p.
7261–7270.